Literature DB >> 10455898

Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation.

F T Thomas1, J L Contreras, G Bilbao, C Ricordi, D Curiel, J M Thomas.   

Abstract

BACKGROUND: Isolated cell transplantation (ICT) of pancreatic islets (PI), nerve tissue, hepatocytes, and other cells is an exciting new concept of transplantation. PI transplantation can be successful in reversing diabetes but, unlike whole pancreas, grafts have a unique and unexplained high failure rate, with over 60% loss by 3 to 6 months. We established that PI of rhesus monkeys have a high rate of death within 48 hours of isolation as a result of apoptosis, as measured with the Annexin V assay (Pharmingen, San Diego, Calif). In contrast, PI incompletely separated from the extracellular matrix (ECM) remained viable for prolonged periods in culture and performed superiorly in perifusion assays (insulin secretion of 4.6 +/- 0.8 times basal secretion).
METHODS: We studied the ability of the anti-AP Bcl-2 molecule, known to block anoikis (a mechanism of AP due to cell-ECM separation), to prevent apoptosis of isolated PI.
RESULTS: PI transduced with an adenovirus-Bcl-2 gene complex showed a high viability and a low AP rate in culture versus control rhesus PI.
CONCLUSION: In summary, PI protected from AP by a surrounding ECM mantle or by Adenovirol Vector (AdV) transduction of the Bcl-2 gene showed superior viability without AP in vitro and in vivo evidence of a preserved insulin secretion response to glucose.

Entities:  

Mesh:

Year:  1999        PMID: 10455898

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  34 in total

Review 1.  Advancing islet transplantation: from engraftment to the immune response.

Authors:  R F Gibly; J G Graham; X Luo; W L Lowe; B J Hering; L D Shea
Journal:  Diabetologia       Date:  2011-08-10       Impact factor: 10.122

Review 2.  Enzyme Development for Human Islet Isolation: Five Decades of Progress or Stagnation?

Authors:  Daniel Brandhorst; Heide Brandhorst; Paul R V Johnson
Journal:  Rev Diabet Stud       Date:  2017-06-12

3.  Adenoviral overproduction of interleukin-1 receptor antagonist increases beta cell replication and mass in syngeneically transplanted islets, and improves metabolic outcome.

Authors:  N Téllez; M Montolio; E Estil-les; J Escoriza; J Soler; E Montanya
Journal:  Diabetologia       Date:  2007-01-13       Impact factor: 10.122

4.  Small intestinal submucosa improves islet survival and function during in vitro culture.

Authors:  Xiao-Hui Tian; Wu-Jun Xue; Xiao-Ming Ding; Xin-Lu Pang; Yan Teng; Pu-Xun Tian; Xin-Shun Feng
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

5.  Cell-matrix interactions improve beta-cell survival and insulin secretion in three-dimensional culture.

Authors:  Laney M Weber; Kirsten N Hayda; Kristi S Anseth
Journal:  Tissue Eng Part A       Date:  2008-12       Impact factor: 3.845

6.  Collagen IV-modified scaffolds improve islet survival and function and reduce time to euglycemia.

Authors:  Woon Teck Yap; David M Salvay; Michael A Silliman; Xiaomin Zhang; Zachary G Bannon; Dixon B Kaufman; William L Lowe; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2013-06-27       Impact factor: 3.845

Review 7.  Re-engineering islet cell transplantation.

Authors:  Nicoletta Fotino; Carmen Fotino; Antonello Pileggi
Journal:  Pharmacol Res       Date:  2015-03-23       Impact factor: 7.658

8.  Transplantation of heterospheroids of islet cells and mesenchymal stem cells for effective angiogenesis and antiapoptosis.

Authors:  Jung-Youn Shin; Jee-Heon Jeong; Jin Han; Suk Ho Bhang; Gun-Jae Jeong; Muhammad R Haque; Taslim A Al-Hilal; Myungkyung Noh; Youngro Byun; Byung-Soo Kim
Journal:  Tissue Eng Part A       Date:  2015-02-05       Impact factor: 3.845

9.  Limitations in the Use of Fluorescein Diacetate/Propidium Iodide (FDA/PI) and Cell Permeable Nucleic Acid Stains for Viability Measurements of Isolated Islets of Langerhans.

Authors:  Vinc Boyd; Olivia Maria Cholewa; Klearchos K Papas
Journal:  Curr Trends Biotechnol Pharm       Date:  2008-03

Review 10.  Can We Re-Engineer the Endocrine Pancreas?

Authors:  Antonio Citro; Harald C Ott
Journal:  Curr Diab Rep       Date:  2018-10-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.